NCT06475222

Brief Summary

This study consisted of three sub-studies including 1) development and evaluation of facial serum from Thai rice on skin moisture, elasticity, oiliness, and melanin in healthy participants 2) development and evaluation of facial mask from Thai rice on skin moisture, elasticity, oiliness, and melanin in healthy participants and 3) development and evaluation of ready-to-drink jelly from Thai rice on controlling blood glucose and endurance time in healthy participants.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
104

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 20, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

June 26, 2024

Completed
2 months until next milestone

Study Start

First participant enrolled

September 1, 2024

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2024

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

February 10, 2025

Status Verified

February 1, 2025

Enrollment Period

3 months

First QC Date

June 20, 2024

Last Update Submit

February 7, 2025

Conditions

Keywords

Thai rice

Outcome Measures

Primary Outcomes (11)

  • Level of skin moisture

    Studies 1 and 2 determine level of skin moisture in arbitrary unit (no unit) using Multiprobe Adapter System with Corneometer® CM 825 probe.

    Before intervention, immediately after intervention, ends of week 4, week 8, and week 12]

  • Level of skin elasticity

    Studies 1 and 2 determine level of skin elasticity in arbitrary unit (no unit) using Multiprobe Adapter System with Cutometer® 580 probe.

    Before intervention, immediately after intervention, ends of week 4, week 8, and week 12]

  • Level of skin oiliness

    Studies 1 and 2 determine level of skin oiliness in arbitrary unit (no unit) using Multiprobe Adapter System with Sebumeter® SM 815 probe.

    Before intervention, immediately after intervention, ends of week 4, week 8, and week 12]

  • Level of skin melanin

    Studies 1 and 2 determine level of skin melanin in arbitrary unit (no unit) using Multiprobe Adapter System with Mexameter® MX18 probe.

    Before intervention, immediately after intervention, ends of week 4, week 8, and week 12]

  • Level of blood glucose

    Study 3.1 determines level of blood glucose in mg/dL unit

    Before jelly consumption and after jelly consumption at 30, 60, 90, and 120 minutes

  • Level of maximal oxygen consumption

    Study 3.2 determines level of maximal oxygen consumption in mL/kg/min unit by walking or running on treadmill at intensity of 80% maximal heart rate.

    After jelly consumption for 30 minutes

  • Concentration of interferon-gamma

    Study 3.2 determines concentration of interferon-gamma in serum in pg (picogram)/mL unit

    Before and immediately after maximal oxygen consumption test

  • Concentration of tumor necrosis factor-alpha

    Study 3.2 determines concentration of tumor necrosis factor-alpha in serum in pg (picogram)/mL unit

    Before and immediately after maximal oxygen consumption test

  • Concentration of interleukin-10

    Study 3.2 determines concentration of interleukin-10 in serum in pg (picogram)/mL unit

    Before and immediately after maximal oxygen consumption test

  • Level of superoxide dismutase activity

    Study 3.2 determines level of superoxide dismutase activity in percentage (%) unit

    Before and immediately after maximal oxygen consumption test

  • Concentration of malondialdehyde

    Study 3.2 determines concentration of malondialdehyde in micromolar (uM) unit

    Before and immediately after maximal oxygen consumption test

Study Arms (6)

Study 1: Facial serum with alpha albutin

ACTIVE COMPARATOR

Participants will be randomly applied with home-based program of facial serum producing from 2% alpha albutin (standard facial serum) on either right side or left side of their face daily for 12 weeks.

Other: Study 1: Facial serum with alpha albutin

Study 1: Facial serum with Tubtim Chumpae rice extract

EXPERIMENTAL

Participants will be randomly applied with home-based program of facial serum producing from Tubtim Chumpae rice extract on either right side or left side of their face daily for 12 weeks.

Other: Study 1: Facial serum with Tubtim Chumpae rice extract

Study 2: Facial mask with Hom Pathum rice extract

EXPERIMENTAL

Participants will receive home-based program of facial mask with Hom Pathum rice extract for 30 min/day, 2 days/week for 12 weeks.

Other: Study 2: Facial mask with Hom Pathum rice extract

Study 3: Control jelly

ACTIVE COMPARATOR

Participants will consume with control jelly at 3.5 g/kg body weight. Consumption will be taken at Burapha University.

Other: Study 3: Control jelly

Study 3: Jelly with Tubtim Chumpae rice

EXPERIMENTAL

Participants will consume with Tubtim Chumpae rice jelly at 3.5 g/kg body weight. Consumption will be taken at Burapha University.

Other: Study 3: Jelly with Tubtim Chumpae rice

Study 3: Jelly with Hom Pathum rice

EXPERIMENTAL

Participants will consume with Hom Pathum rice jelly at 3.5 g/kg body weight. Consumption will be taken at Burapha University.

Other: Study 3: Jelly with Hom Pathum rice

Interventions

Applying with facial serum with 2% alpha albutin as active comparator daily for 12 weeks.

Study 1: Facial serum with alpha albutin

Applying with facial serum with Tubtim Chumpae rice extract as experimental intervention daily for 12 weeks.

Study 1: Facial serum with Tubtim Chumpae rice extract

Applying with facial mask with Hom Pathum rice extract as experimental intervention for 30 min/day, 2 days/week for 12 weeks.

Study 2: Facial mask with Hom Pathum rice extract

Consumption with control jelly as active comparator at 3.5 g/kg body weight.

Study 3: Control jelly

Consumption with jelly with Tubtim Chumpae rice as experimental intervention at 3.5 g/kg body weight.

Study 3: Jelly with Tubtim Chumpae rice

Consumption with jelly with Hom Pathum rice as experimental intervention at 3.5 g/kg body weight.

Study 3: Jelly with Hom Pathum rice

Eligibility Criteria

Age18 Years - 50 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Male or female
  • Age between 18 to 50 years
  • Healthy
  • Interested in facial serum with Thai rice extract or facial mask with Thai rice extract or jelly from with Thai rice

You may not qualify if:

  • History of adverse effects from facial serum or mask application or jelly consumption
  • Skin allergy
  • Skin disorders
  • Skin wounds
  • History of allergy to Thai rice, particularly in Tubtim Chumpae and Hom Pathum
  • History of allergy to facial serum or mask, i.e., serum or mask from rice
  • History of allergy to gelatin
  • Signs or symptoms of fever or infection
  • Abnormal body mass index
  • Regular smokers or alcohol drinkers (\>2 times per week)
  • Regular exerciser (\>2 times per week or \>150 min per week)
  • Regular intake of dietary supplements, i.e., vitamins, antioxidants
  • Hypertension, diabetes, cardiovascular disease, respiratory disease, endocrine disease, neuromuscular disease, musculoskeletal disease, liver disease, renal disease, immune disease, infectious disease, or cancer

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Piyapong Prasertsri

Mueang, Changwat Chon Buri, 20131, Thailand

Location

Study Officials

  • Piyapong Prasertsri, Ph.D.

    Burapha University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: Study 1 is single group model, study 2 is parallel model, and study 3 is crossover model.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor Dr.

Study Record Dates

First Submitted

June 20, 2024

First Posted

June 26, 2024

Study Start

September 1, 2024

Primary Completion

November 30, 2024

Study Completion

December 31, 2024

Last Updated

February 10, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will not share

There is no plan to make individual participant data available to other researchers.

Locations